These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 3510078)

  • 1. Biological and biochemical properties of human rasH genes mutated at codon 61.
    Der CJ; Finkel T; Cooper GM
    Cell; 1986 Jan; 44(1):167-76. PubMed ID: 3510078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumorigenicity, metastasis and suppression of MHC class-I expression in murine fibroblasts transformed by mutant v-ras deficient in GTP binding.
    Lu YY; Blair DG; Segal S; Shih TY; Clanton DJ
    Int J Cancer Suppl; 1991; 6():45-53. PubMed ID: 2066184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion mutants of Harvey ras p21 protein reveal the absolute requirement of at least two distant regions for GTP-binding and transforming activities.
    Lacal JC; Anderson PS; Aaronson SA
    EMBO J; 1986 Apr; 5(4):679-87. PubMed ID: 3011420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship among guanine nucleotide exchange, GTP hydrolysis, and transforming potential of mutated ras proteins.
    Feig LA; Cooper GM
    Mol Cell Biol; 1988 Jun; 8(6):2472-8. PubMed ID: 3043178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical and biological properties of the human N-ras p21 protein.
    Trahey M; Milley RJ; Cole GE; Innis M; Paterson H; Marshall CJ; Hall A; McCormick F
    Mol Cell Biol; 1987 Jan; 7(1):541-4. PubMed ID: 3550423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternate mechanisms of ras activation are complementary and favor and formation of ras-GTP.
    Patel G; MacDonald MJ; Khosravi-Far R; Hisaka MM; Der CJ
    Oncogene; 1992 Feb; 7(2):283-8. PubMed ID: 1549350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical characterization of polypeptides encoded by mutated human Ha-ras1 genes.
    Colby WW; Hayflick JS; Clark SG; Levinson AD
    Mol Cell Biol; 1986 Feb; 6(2):730-4. PubMed ID: 3537694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GTP hydrolysis mechanisms in ras p21 and in the ras-GAP complex studied by fluorescence measurements on tryptophan mutants.
    Antonny B; Chardin P; Roux M; Chabre M
    Biochemistry; 1991 Aug; 30(34):8287-95. PubMed ID: 1883817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative biochemical properties of normal and activated human ras p21 protein.
    McGrath JP; Capon DJ; Goeddel DV; Levinson AD
    Nature; 1984 Aug 23-29; 310(5979):644-9. PubMed ID: 6147754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-regulation of metastatic and transforming activity of normal and mutant ras genes.
    Egan SE; Broere JJ; Jarolim L; Wright JA; Greenberg AH
    Int J Cancer; 1989 Mar; 43(3):443-8. PubMed ID: 2784421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The product of the cph oncogene is a truncated, nucleotide-binding protein that enhances cellular survival to stress.
    Velasco JA; Avila MA; Notario V
    Oncogene; 1999 Jan; 18(3):689-701. PubMed ID: 9989819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical and biological activities of N-ras proteins.
    Geis AM; Nicolson M; Goldman RA
    Biochem Biophys Res Commun; 1986 Sep; 139(2):771-9. PubMed ID: 3533068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. rasH mutants deficient in GTP binding.
    Der CJ; Pan BT; Cooper GM
    Mol Cell Biol; 1986 Sep; 6(9):3291-4. PubMed ID: 3097518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulators and effectors of ras proteins.
    Bollag G; McCormick F
    Annu Rev Cell Biol; 1991; 7():601-32. PubMed ID: 1667084
    [No Abstract]   [Full Text] [Related]  

  • 15. GTPase-inhibiting mutations in the alpha subunit of Gs.
    Masters SB; Landis CA; Bourne HR
    Adv Second Messenger Phosphoprotein Res; 1990; 24():70-5. PubMed ID: 2119660
    [No Abstract]   [Full Text] [Related]  

  • 16. trans-Dominant suppressor mutations of the H-ras oncogene.
    Ogiso Y; Gutierrez L; Wrathall LS; Lu YY; Blair DG; Clanton DJ; Hwang YW; Shih TY
    Cell Growth Differ; 1990 May; 1(5):217-24. PubMed ID: 2150753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies specific for amino acid 12 of the ras oncogene product inhibit GTP binding.
    Clark R; Wong G; Arnheim N; Nitecki D; McCormick F
    Proc Natl Acad Sci U S A; 1985 Aug; 82(16):5280-4. PubMed ID: 3927300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-dimensional structures and properties of a transforming and a nontransforming glycine-12 mutant of p21H-ras.
    Franken SM; Scheidig AJ; Krengel U; Rensland H; Lautwein A; Geyer M; Scheffzek K; Goody RS; Kalbitzer HR; Pai EF
    Biochemistry; 1993 Aug; 32(33):8411-20. PubMed ID: 8357792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ras gene family.
    Lowy DR; Willumsen BM
    Cancer Surv; 1986; 5(2):275-89. PubMed ID: 3096566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ras p21 proteins with high or low GTPase activity can efficiently transform NIH/3T3 cells.
    Lacal JC; Srivastava SK; Anderson PS; Aaronson SA
    Cell; 1986 Feb; 44(4):609-17. PubMed ID: 3004741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.